Zydus Lifesciences transmits 10,000 shares to promoter group member
Zydus Lifesciences Limited disclosed the transmission of 10,000 equity shares from Late Jasodaben Babubhai Patel to Mr. Samar Babubhai Patel, a member of the Promoter Group. The off-market transaction was executed on May 22, 2026, and intimated to the company on May 25, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
*this image is generated using AI for illustrative purposes only.
Zydus Lifesciences Limited disclosed the transmission of 10,000 equity shares from Late Jasodaben Babubhai Patel to Mr. Samar Babubhai Patel, a member of the Promoter Group. The transaction was executed off-market on May 22, 2026, and the company received the intimation regarding this change on May 25, 2026. The disclosure was submitted to the stock exchanges in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The transfer of shares was necessitated by the death of Late Jasodaben Babubhai Patel, who was also a member of the Promoter Group. Following the transmission, Mr. Samar Babubhai Patel now holds 10,000 equity shares, representing 0.00% of the company's shareholding. The details of the change in holding were formally communicated to BSE Limited and the National Stock Exchange of India Limited by Dhaval N. Soni, Company Secretary and Compliance Officer of Zydus Lifesciences Limited.
Shareholding Details
The disclosure outlines the specific details of the securities held prior to and post the transmission. The transaction did not involve any trading in derivatives, as indicated in the filing.
| Particulars | Details |
|---|---|
| Name of Acquirer | Samar Babubhai Patel |
| Category | Promoter Group |
| Type of Security | Equity Shares |
| Securities Acquired | 10,000 |
| Mode of Acquisition | Off Market (Transmission) |
| Date of Acquisition | May 22, 2026 |
| Date of Intimation | May 25, 2026 |
| Pre-acquisition Holding | 0 (0.00%) |
| Post-acquisition Holding | 10,000 (0.00%) |
The filing confirms that no derivatives were traded by the promoter group member during this period. The company has ensured that all necessary procedural requirements were met in informing the exchanges about the change in shareholding.
Historical Stock Returns for Zydus Life Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.63% | +6.57% | +17.08% | +15.44% | +18.95% | +72.87% |
Does this transmission signal a broader restructuring of the promoter group's holdings?
Will Mr. Samar Babubhai Patel increase his stake in the company through open market purchases?
How might this change in promoter group composition influence the company's strategic direction?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
